Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Sep 13:2018:3232105.
doi: 10.1155/2018/3232105. eCollection 2018.

Primary Carnitine Deficiency: A Rare, Reversible Metabolic Cardiomyopathy

Affiliations
Case Reports

Primary Carnitine Deficiency: A Rare, Reversible Metabolic Cardiomyopathy

Stephen Tomlinson et al. Case Rep Cardiol. .

Abstract

A 24-year-old female with a diagnosis of primary carnitine deficiency, a rare inherited metabolic disorder predominantly described in the paediatric literature that causes cardiomyopathy, presented for evaluation after three months of nonadherence with prescribed carnitine therapy. Initial echocardiography demonstrated severe left ventricular dilation (104 ml/m2) (normal < 76 ml/m2) with moderate systolic dysfunction (ejection fraction 40%) and severe right ventricular dilation with mild systolic dysfunction. Carnitine replacement was commenced, and a cardiac magnetic resonance imaging (MRI) performed five days later demonstrated dramatic improvement in biventricular function with normalization of left and right ventricular systolic function. To our knowledge, this is only the second case describing the rapid reversal of cardiomyopathy in an adult patient with this rare condition.

PubMed Disclaimer

Figures

Figure 1
Figure 1
12-lead electrocardiogram taken on admission demonstrating peaked T waves and short QT interval.
Figure 2
Figure 2
Echocardiogram on the day of presentation in (a) diastole and (b) systole (bar scale: one integer = 1 cm).
Figure 3
Figure 3
Cardiac MRI postcarnitine replacement in (a) diastole and (b) systole.

References

    1. El-Hattab A. W., Scaglia F. Disorders of carnitine biosynthesis and transport. Molecular Genetics and Metabolism. 2015;116(3):107–112. doi: 10.1016/j.ymgme.2015.09.004. - DOI - PubMed
    1. Magoulas P. L., El-Hattab A. W. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet Journal of Rare Diseases. 2012;7(1):p. 68. doi: 10.1186/1750-1172-7-68. - DOI - PMC - PubMed
    1. Fu L., Huang M., Chen S. Primary carnitine deficiency and cardiomyopathy. Korean Circulation Journal. 2013;43(12):785–792. doi: 10.4070/kcj.2013.43.12.785. - DOI - PMC - PubMed
    1. Ascunce R. R., Nayar A. C., Phoon C. K., Srichai M. B. Cardiac magnetic resonance findings in a case of carnitine deficiency. Texas Heart Institute Journal. 2013;40(1):104–105. - PMC - PubMed
    1. Wang S. S., Rao J., Li Y. F., Zhang Z. W., Zeng G. H. Primary carnitine deficiency cardiomyopathy. International Journal of Cardiology. 2014;174(1):171–173. doi: 10.1016/j.ijcard.2014.03.190. - DOI - PubMed

Publication types

LinkOut - more resources